Table 1.
Examples of polymeric systems designed for brain delivery of antiangiogenesis compounds
| Technique of delivery | Antiangiogenic factor | Polymer | Reference |
| Cell encapsulation | Endostatin, Interferon-□, Angiostatin | Alginate/PLL | 59–62 |
| Non-viral gene therapy | interleukin-12 | PPC | 64, 65 |
| Biodegradable matrices/Nano/micro particles | PEX, PF4/CTF, heparin minocycline, | PLGA, pCPP:SA, PEG | 54–56 |
| Polymer conjugations/ | interferon alpha, | HPMA, | 82, 83, 87 |
| Polymeric micelles | TNP-470 | mPEG-PLA |
This list is partial and includes only direct antiangiogenic factors studied in brain tumors. PLL, Poly L-lysine; PLGA, Poly-(lactic-co-glycolic)acid; pCPP:SA, poly[bis(p-carboxyphenoxy)propane-sebacic acid]; PPC, polyethylenimine—methoxypolyethyleneglycol and cholesterol; PEG, Polyethylene glycol.